BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23545055)

  • 1. Clinical trials in cellular immunotherapy for brain/CNS tumors.
    Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
    Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The innate immune response in the central nervous system and its role in glioma immune surveillance.
    Friese MA; Steinle A; Weller M
    Onkologie; 2004 Oct; 27(5):487-91. PubMed ID: 15585981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
    Kubo O; Takakura K
    Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
    Pollack IF; Okada H; Chambers WH
    Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy of CNS malignancies.
    Plautz GE; Shu S
    Cancer Chemother Biol Response Modif; 2001; 19():327-38. PubMed ID: 11686021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications.
    Yang MY; Zetler PM; Prins RM; Khan-Farooqi H; Liau LM
    Expert Rev Neurother; 2006 Oct; 6(10):1481-94. PubMed ID: 17078788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
    Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
    J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virally mediated immunotherapy for brain tumors.
    Agarwalla PK; Barnard ZR; Curry WT
    Neurosurg Clin N Am; 2010 Jan; 21(1):167-79. PubMed ID: 19944975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past, present, and future strategies in the treatment of high-grade glioma in children.
    Broniscer A
    Cancer Invest; 2006 Feb; 24(1):77-81. PubMed ID: 16466996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing boundaries in the treatment of malignant gliomas.
    Brandes AA; Basso U; Pasetto LM
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):357-70. PubMed ID: 12113103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 18. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
    Akasaki Y; Black KL; Yu JS
    Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity and immunotherapy of brain tumors.
    Prins RM; Liau LM
    Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of high grade malignant gliomas in adults: an overview.
    Brandes A; Soesan M; Fiorentino MV
    Anticancer Res; 1991; 11(2):719-27. PubMed ID: 2064325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.